株式会社ユカリア Logo

株式会社ユカリア

Management, DX, and data solutions for healthcare and long-term care providers.

286A | T

Overview

Corporate Details

ISIN(s):
JP3946900002
LEI:
Country:
Japan
Address:
千代田区霞が関3丁目2番5号 霞が関ビルディング19階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Eucalia Inc. is a healthcare services company dedicated to transforming the medical and long-term care sectors. Its core business is providing management and operational support for hospitals and care facilities. The company offers a comprehensive suite of services, including management consulting, medical digital transformation (DX) solutions, and medical data utilization. Eucalia also directly operates facilities for the elderly. Its client base includes hospitals, care facilities, pharmaceutical companies, and academic institutions. The company operates on the principle of 'Sanpo-yoshi' (good for all three parties), aiming to build a sustainable ecosystem that improves the quality of life for facility management, healthcare workers, and patients alike, thereby strengthening the social infrastructure of care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 09:21
Interim Report
確認書
Japanese 8.6 KB
2025-08-14 09:19
Interim Report
半期報告書-第21期(2025/01/01-2025/12/31)
Japanese 295.4 KB
2025-06-18 02:30
M&A Activity
臨時報告書
Japanese 20.2 KB
2025-06-05 09:46
Regulatory News Service
臨時報告書
Japanese 32.5 KB
2025-05-15 09:01
M&A Activity
臨時報告書
Japanese 30.0 KB
2025-05-15 07:43
M&A Activity
臨時報告書
Japanese 29.9 KB
2025-03-28 06:37
Post-Annual General Meeting Information
臨時報告書
Japanese 25.3 KB
2025-03-28 06:36
Registration Form
確認書
Japanese 8.6 KB
2025-03-28 06:36
Governance Information
内部統制報告書-第20期(2024/01/01-2024/12/31)
Japanese 23.3 KB
2025-03-28 06:35
Annual Report
有価証券報告書-第20期(2024/01/01-2024/12/31)
Japanese 2.0 MB
2025-02-17 02:05
Regulatory News Service
臨時報告書
Japanese 27.0 KB
2024-12-03 07:30
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.1 MB
2024-11-25 07:30
Regulatory News Service
訂正有価証券届出書(新規公開時)
Japanese 2.1 MB
2024-11-08 07:30
Registration Form
有価証券届出書(新規公開時)
Japanese 4.0 MB
2024-03-29 07:00
Foreign Filer Report
親会社等状況報告書(内国会社)-第19期(2023/01/01-2023/12/31)
Japanese 25.1 KB

Automate Your Workflow. Get a real-time feed of all 株式会社ユカリア filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社ユカリア

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社ユカリア via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.